FibroBiologics, Inc. SEC filings FBLG
FibroBiologics, Inc. has 242 filings in SEC EDGAR's recent list, going back to Jan 31, 2023. Its latest annual report, Form ARS, was filed on May 5, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Jul 31, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 8, 2026 (material agreement, new debt, unregistered share sale). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| POS AM | Filing | Oct 13, 2026 | — |
| POS AM | Filing | Oct 13, 2026 | — |
| 424B3 | Prospectus | Jul 16, 2026 | — |
| S-3 | Shelf registration | Jul 10, 2026 | — |
| 424B5 | Prospectus supplement | May 6, 2026 | — |
| 424B5 | Prospectus supplement | May 1, 2026 | — |
| 424B4 | Prospectus | Apr 1, 2026 | — |
| S-1 | Registration statement | Mar 27, 2026 | — |
| 424B3 | Prospectus | Dec 30, 2025 | — |
| S-1 | Registration statement | Dec 23, 2025 | — |
| 424B5 | Prospectus supplement | Dec 15, 2025 | — |
| 424B5 | Prospectus supplement | Nov 25, 2025 | — |
| 424B5 | Prospectus supplement | Nov 20, 2025 | — |
| S-3 | Shelf registration | Feb 3, 2025 | — |
| POS AM | Filing | Jan 17, 2025 | — |
| 424B4 | Prospectus | Jan 14, 2025 | — |
| S-1/A | Amended registration statement | Jan 10, 2025 | — |
| S-1 | Registration statement | Dec 30, 2024 | — |
| POS AM | Filing | Aug 13, 2024 | — |
| 424B4 | Prospectus | Jun 26, 2024 | — |
| S-1 | Registration statement | Jun 18, 2024 | — |
| S-1/A | Amended registration statement | Jun 4, 2024 | — |
| S-1/A | Amended registration statement | May 15, 2024 | — |
| S-8 | Employee stock plan registration | May 15, 2024 | — |
| S-1 | Registration statement | Apr 26, 2024 | — |
| 424B4 | Prospectus | Mar 28, 2024 | — |
| S-1/A | Amended registration statement | Mar 26, 2024 | — |
| S-1/A | Amended registration statement | Mar 15, 2024 | — |
| S-1 | Registration statement | Feb 12, 2024 | — |
| 424B4 | Prospectus | Jan 31, 2024 | — |
| S-1/A | Amended registration statement | Jan 24, 2024 | — |
| S-1/A | Amended registration statement | Jan 24, 2024 | — |
| S-1/A | Amended registration statement | Jan 22, 2024 | — |
| S-1/A | Amended registration statement | Jan 12, 2024 | — |
| FWP | Free writing prospectus | Dec 14, 2023 | — |
| S-1/A | Amended registration statement | Dec 7, 2023 | — |
| S-1/A | Amended registration statement | Dec 4, 2023 | — |
| S-1/A | Amended registration statement | Nov 30, 2023 | — |
| S-1/A | Amended registration statement | Nov 28, 2023 | — |
| S-1 | Registration statement | Nov 7, 2023 | — |
Showing 40 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- FBLG (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Houston, TX
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1958777
- Former names
- FibroBiologics Inc. (until Feb 6, 2024)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.